Cyclica Announces Launch of Ligand DesignTM

Cyclica has announced its novel, first-in-class drug design technology, Ligand DesignTM which empowers scientists in the pharmaceutical industry to generate novel drug-like compounds by combining powerful methods for molecule generation, ADMET prediction, and high-throughput ligand-protein interaction prediction.

Click here to learn more

Previous
Previous

Apply for Sunnybrook's Fall Medventions Internship Program

Next
Next

$100 M Endowment Fund Announced for Health Sciences Research in Hamilton